Condition
Ground-glass Opacity
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06848881Not ApplicableRecruitingPrimary
Cryoablation vs Thoracoscopic Surgery for GGN
NCT07389889Not ApplicableNot Yet Recruiting
Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity
NCT06102161Phase 3Not Yet Recruiting
Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)
Showing all 3 trials